Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.28 - $1.16 $512 - $2,123
-1,831 Reduced 2.27%
78,950 $26,000
Q1 2024

May 07, 2024

SELL
$1.06 - $1.67 $1,272 - $2,004
-1,200 Reduced 1.46%
80,781 $93,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $45,780 - $65,037
36,334 Added 79.6%
81,981 $138,000
Q2 2023

Aug 11, 2023

SELL
$1.14 - $1.95 $3,227 - $5,520
-2,831 Reduced 5.84%
45,647 $84,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.19 $58,173 - $106,166
48,478 New
48,478 $64,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.